lymphoma hub

15-ICML, 18 June 2019

Nathan Fowler

Nathan Fowler

University of Texas MD Anderson Cancer Centre
Houston, TX, USA
Follow on Twitter: @DrNathanFowler

Nathan Fowler is Assistant Professor in the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Professor Fowler received his MD and completed his residence at the University of Texas, before completing a clinical fellowship in hematology/oncology at Georgetown University where he was a chief fellow.

His focus at MD Anderson has been the further development of novel therapeutic regimens with immunomodulatory therapies to help patients with low-grade non-Hodgkin lymphoma (NHL). He also serves as the chairman of several phase I and investigator-initiated phase II trials for patients with NHL.

Positions of responsibility/awards:

  • Co-Director of the Clinical Investigational and Translational Research Program at The University of Texas MD Anderson Cancer Center (2012–2018)
  • Member of the National Cancer Institute (NCI), Follicular Lymphoma Sub Committee
  • Member of the Southwest Oncology Group (SWOG), Lymphoma Steering Committee (2013–present)
  • Advisor of the Clinical Research Advisory Committee (2012–present)
  • Member of the Clinical Effectiveness Subcommittee (2010–present)
  • Member of the Clinical Research Committee (2009–2016)
  • Georgetown Chief Fellow
  • Natural Science and Mathematics Scholar and Fellow
  • Order of Omega Greek Honor Society
  • Dean's List

This site uses cookies in order for us to continually develop and improve the service we can offer you.Read more